Removal of Cryptosporidium parvum oocysts and Cryptosporidium-sized microspheres was evaluated in full-scale swimming pools via high-rate sand filtration (31-34 m/h) with coagulation.
finalized in 2005 and further required water utilities classified in higher risk treatment bins (or categories) to provide an additional 90% to 99.7% (1.0 to 2.5 log) removal of Cryptosporidium (USEPA ). Control of Cryptosporidium in drinking water requires an integrated multiple-barrier approach (Edzwald & Kelley ; Edzwald et al. ); this requirement is enforced by the USEPA. However, swimming pools are different than drinking water systems (e.g., swimming pools are operated as recirculated water systems, whereas drinking water systems are single pass), and pool water treatment is different from drinking water treatment, both in practice and in degree of treatment required because pool water is not meant to be consumed. Coagulation and flocculation are conducted almost exclusively prior to filtration in drinking water treatment, thereby neutralizing the surface charge and increasing the size of particles entering the filter, which can increase filter performance based on continuously monitored turbidity measurements to exceed the minimum required Cryptosporidium reduction of 99%. Coagulation is not typically conducted in US swimming pools, and it has been reported that only approximately 20% to 60% of Cryptosporidium-sized microspheres were removed by sand filters without coagulation (Croll et al. ; Amburgey ) . Drinking water treatment plants typically operate filters at four to five times lower surface loading rates than swimming pool facilities, 4.9 to 10 m/h (2 to 4 gpm/ft 2 ) rather than 37 to 49 m/h (15 to 20 gpm/ft 2 ) for swimming pools. This reduction in filtration rate for drinking water treatment filters lowers the velocity of particles in the filter and provides a higher probability of particles colliding with and adhering to the filter media (Lu et al. ) .
Swimming pools typically use pressure sand filters, either designed for vertical downward flow or horizontal flow.
There should be at least two filters for all public pools for redundancy. Filters are normally rated on the basis of flow rate per unit surface area (e.g., m 3 /m 2 /h), and the filtration rate is classified as low (<20 m/h), medium (20-30 m/h), or high (30-50 m/h) (Lu ). High-rate filters are usually installed for club, hotel, and private pools, and medium-rate filters are recommended for public school pools (Lu ).
Pressure sand filters are typically backwashed when the filter influent pressure increases 1.5 kPa (10 psi) or more (or as required depending on the efficiency of the filter in removing suspended and colloidal matter). As the particles accumulate in the filter, there is a loss of pressure (or head) through the filter, which is typically measured by pressure gauges on the water pipes leading to and from the filter (one near the top of the filter and the other near the bottom). When coagulation is performed in pools, the treatment systems may be comprised of a strainer, coagulant dosing equipment, and pressure filter as depicted in Figure 1 .
The addition of a coagulant is standard practice in Europe, but it not standard practice in the USA where filters beds are often not as deep and filter loading rates are higher than in European pool systems.
The addition of alum has been shown to significantly improve removals of Cryptosporidium-sized microspheres to greater than 1 log in a single pass with continuous doses of 0.1 mg/L as Al and filter loading rates of 25 m/h and 60 cm of sand media (Goodman ) . The addition of polyaluminum chloride (PACl) at a continuous dosage of 0.1 mg/L as Al was able to remove greater than 2 log (99%) Cryptosporidium-sized microspheres in a single pass with a 25 m/h filter loading rate and 60 cm of sand media (Goodman ) . However, the same study reported that sand filter removals with alum declined to less than 90% when the filter bed depth was decreased from 60 cm to 30 cm, the filtration rate was increased from 25 to 37 m/h, or both (Goodman ) . Decreasing the bed depth or increasing the filtration rate was shown to reduce PACl (0.1 mg/L as Al) removals from greater than 2 log to greater than 1 log. The problem with both alum and PACl is that when used in filters with 30 cm of sand at a filter loading rate of 37 m/h the removal of Cryptosporidium-sized particles is consistently less than 1 log (Goodman ). Unfortunately, many existing pool filters and state pool codes in the USA have maximum filtration rates of 37 m/h or higher with no minimum sand depth. Based on the Goodman study results, many US pools could realize significant benefits in pathogen removal from practicing coagulation, but there are many others that would not be expected to benefit (without modifying their existing filtration/recirculation systems) due to prohibitively high filtration rates and shallow bed depths.
Another study found that removals of 1.6 log (97%) could be The increasing demand for recreational water activities combined with Cryptosporidium outbreaks has pushed the research on Cryptosporidium removal from swimming pools to the forefront. The primary objective of this study was to examine the removal of C. parvum oocysts and Cryptosporidium sized-microspheres by high-rate sand filtration with four different coagulants in full-scale swimming pools to verify field-relevant performance. Four types of coagulants were independently added to separate full-scale swimming pools, and particle removals were determined after one and multiple passes through the filter system.
MATERIALS AND METHODS

Experimental materials
The experiments were conducted at the Lonza Test Pool Facility in Conley, GA, USA. and coagulants D and E were aluminum-based coagulants.
The formulation of coagulant F is proprietary. All of these coagulants were shown to be effective in a pilot-scale swimming pool study, and the coagulant designations were retained from the original study for consistency (Lu ;
Lu & Amburgey ).
C. parvum oocysts and Cryptosporidium-sized polystyrene microspheres were mixed and fed into the swimming pool. Heat-inactivated C. parvum oocysts (Iowa strain) at 55 W C were used in these experiments. Oocysts produced in experimentally infected bovine calves were purified from calf feces by sucrose and cesium chloride gradients and stored in phosphate-buffered saline with antibiotics and 0.01% Tween 20 at 4 W C for approximately 7.5 months.
Samples were concentrated using two centrifugation steps at 4,000 × g at 4 W C for 15 minutes followed by two microcentrifugation steps at 15,000 × g at 4 W C for 5 minutes. All The streaming current (SC) created by the charged particles in the pool water was measured by a coagulant charge analyzer (CCA) (Chemtrac, Norcross, GA, USA). SC was on a scale of À10 to 10, rather than À1,000 to 1,000 as was measured by the online SC meter used in a linked pilotscale study (Lu ; Lu & Amburgey ).
Experimental approach
Four coagulants were independently added into the separate pools. Table 1 for the first use to achieve desired particle removal. The continuous dosage was intended to be a 'maintenance dosage' continuously fed into the pool to maintain desired particle removals. The higher continuous dosage was used to test whether each coagulant was likely to cause an overdose by continuously feeding coagulant. Pilot-scale study results indicated that microsphere removals decreased to less Approximately 1.5 oocysts/mL (6 × 10 7 total) and 2.5 microspheres/mL (10 8 total) were seeded into the four separate swimming pools and four coagulants were added at their initial dosage. Coagulants were also fed as one recommended dosage per turnover time to the pool for one month, in order to evaluate the C. parvum oocysts and microsphere removals under continuous dosing conditions. Approximate 1.9 oocysts/mL (1.5 × 10 7 total) and 2.5 microspheres/mL (2 × 10 7 total) were seeded over 60 minutes under continuous dosing conditions to intermittently evaluate filter efficiency.
The collection efficiency was important but not included in this paper because of the limited data. In a pilot-scale study, approximately 1% removal was obtained without filter medium (Lu ) and demonstrated no significant system losses. The set-up for pilot-scale and full-scale studies were similar except for a larger pool. We understand the pilot-scale study cannot equal a full-scale study and just provide the information for your reference.
RESULTS AND DISCUSSION
Filtration with coagulants of control (zero) dosage
Cryptosporidium parvum oocyst and microsphere removals were evaluated without coagulant (zero dosage). Figure 3 shows the C. parvum oocysts and microsphere removals without coagulant in pool #1 to pool #4. The missing data point in Figure 4 occurred because the sample was lost. Control trials showed 38% to 70% removals of C. parvum oocysts and microspheres, which were slightly higher than those in similar pilot-scale experiments (20% to 60%). Pool #4 was initially cloudy, which corresponded with the removal of 70% of C. parvum oocysts and microspheres (i.
e., the highest obtained without coagulation Cryptosporidium parvum oocyst removals were generally lower than those of microspheres in this set of experiments even though the effluent concentrations of both were similar. Although the target seeding concentrations were similar for oocysts and microspheres, the actual influent concentration was <20 oocysts/100 mL, which was much less than the target seeding concentration (∼150 oocysts/ 100 mL) and the other pools' measured influent concentrations (∼100 oocysts/100 mL). The lack of replicate experiments in the experimental design (based on experimental cost at this scale) prevented a better assessment of the variability of this measurement.
Filtration with continuous coagulant dosage
During continuous coagulant feed, C. parvum oocysts and microspheres were fed over 1 hour intervals at concentrations of 1.9 and 2.5 per mL, respectively. Up to 93%
(1.2 log) of C. parvum oocysts and 77% (0.64 log) of microspheres were removed by coagulant B ( Figure 5 ). As high as 99% (2 log) of C. parvum oocysts and 98% (1.7 log) of microspheres were removed with coagulant D (Figure 6 ).
Up to 98% (1.8 log) of C. parvum oocysts and 93%
(1.2 log) of microspheres were removed with coagulant E (Figure 7 ) with higher removals achieved at a dosage of 1.4 mg/L as Al (11.5 mg/L as product) versus dosages of 2 and 2.7 mg/L as Al (16.5 and 21.4 mg/L as product). Two differences were noted during these full-scale experiments with coagulant E: (1) the sample (at 1.4 mg/L as Al) was collected right after a filter backwash while the other samples were not, and (2) the filtration rate increased from 27 m/h (at 1.4 mg/L as Al) to 34 m/h (at 2 and 2.7 mg/L as Al).
The full-scale removals at different filtration rates generally agreed with pilot-scale results that showed microsphere removals were less than 70% at 37 m/h and greater than 90% at 30 m/h (while dosing continuously at 0.1 mg/L as Al). Up to 86% (0.85 log) of C. parvum oocysts and 82%
(0.73 log) of microspheres were removed with coagulant F (Figure 8 ).
Coagulants D and E removed up to 99% of microspheres, which were similar to pilot-scale results of up to 99% (Lu & Amburgey ) . Based on pilot-scale study results, removals of microspheres decreased to less than 90% when coagulants B and F were dosed above a total applied concentration of 4.7 mg/L as product and the SC detector became saturated 
CONCLUSIONS
Cryptosporidium parvum oocyst and microsphere removals from full-scale swimming pools were evaluated, and the following conclusions were drawn based on the results. As high as 99% (2 log) of C. parvum oocysts and 98%
(1.7 log) of microspheres were removed with continuous dosing of coagulant D. Up to 98% (1.7 log) of C. parvum oocysts and 93% (1.1 log) of microspheres were removed
by coagulant E at 27 m/h with continuous coagulation.
The removals with coagulants D and E did not appear to decrease due to coagulant accumulation (or overdosing) since aluminum-based coagulants tend to precipitate at low concentration under near-neutral pH conditions, but removals did decrease with increased filter pressure and/ or increased filtration rates, which could warrant additional research to fully understand the dynamic behavior of these coagulants. Overall, coagulant addition was effective at increasing the removal of Cryptosporidium oocysts from full-scale swimming pools in both remediation (singledose) and continuously dosing scenarios. This study could serve as a guide to more effectively use coagulation in pools since the type of coagulant, dose of coagulant, and filtration rate all play a role in the efficiency of oocyst removal. The findings and conclusions in this report are those of the authors and do not necessarily represent those of the CDC.
